申请人:Kelly Gerard Michael
                            
                            
                                公开号:US20070099911A1
                            
                            
                                公开(公告)日:2007-05-03
                            
                            The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
                            本发明提供了一种I式化合物及其在治疗与5-HT6受体相关或受其影响的中枢神经系统疾病中的用途。